List of Intermediates and Speciality Chemicals
Sr.No. | Structure | Name | CAS No. | Use |
---|---|---|---|---|
1 | ![]() | methyl 7-(3-hydroxy-5- oxocyclopent-1-en-1- yl)heptanoate | 112713-92-5 | Intermediate for Misoprostol |
2 | ![]() | 4-methyloct-1-yn-4-ol | 22128-43-4 | Intermediate for Misoprostol |
3 | ![]() | (E)-((1-iodo-4-methyloct-1- en-4-yl)oxy)trimethylsilane | 62555-05-9 | Intermediate for Misoprostol |
4 | ![]() | 4-(4-ethylpiperazin-1- yl)aniline | 115619-01-7 | Intermediate for Infrigatinib |
5 | ![]() | N4-(4-(4-ethylpiperazin-1- yl)phenyl)-N6- methylpyrimidine-4,6- diamine | 872511-35-8 | Intermediate for Infrigatinib |
6 | ![]() | 2,6-dichloro-3,5- dimethoxyaniline | 872509-56-3 | Intermediate for Infrigatinib |
7 | ![]() | 4-(5-amino-1-methyl-1H- benzimidazol-2-yl)-butyric acid isopropyl ester | 1313020-26-6 | Intermediate for Bendamustine |
8 | ![]() | Ethyl4-(5-amino-1-methyl- 1H-benzo[d]imidazole -2- yl)butanoate | 3543-73-5 | Intermediate for Bendamustine |
9 | ![]() | (3R,4S,5S,6R)-2-[3-[[5-(4- fluorophenyl) thiophen-2- yl] methyl]-4- methylphenyl]-6- (hydroxymethyl)-2- methoxyoxane-3,4,5-triol | 1030825-21-8 | Intermediate for Forodesine/ Galidesivir |
10 | ![]() | (3aR,4R,6aS)-5-benzyl-4- (((tert-butyldimethylsilyl) oxy) methyl)-2,2- dimethyltetrahydro-3aH- [1,3] dioxolo[4,5-c] pyrrole | 153172-30-6 | Intermediate for Forodesine/ Galidesivir |
11 | ![]() | 5-O-tertbutyldiemthylsilyl- 1,4-imino-2,3-O- ispropylidene-D-ribitol | 153172-31-7 | Intermediate for Forodesine/ Galidesivir |
12 | ![]() | ((3aR,4R,6aS)-2,2-Dimethyltetrahydro-3aH- [1,3]dioxolo[4,5-c]pyrrol-4- yl)methanol | 117859-48-0 | Intermediate for Forodesine/Galid esivir |
13 | ![]() | 4-Chloropicolinamide | 99586-65-9 | Speciality chemical |
14 | ![]() | 4-Chloropicolinonitrile | 19235-89-3 | Speciality chemical |
15 | ![]() | Isopropyl 3- fluoroisonicotinate | NA | Speciality chemical |
16 | ![]() | 3-Fluoro picolinamide | NA | Speciality chemical |
17 | ![]() | 1,3-Dibromo-2,2- dimethoxypropane | 22094-18-4 | Speciality chemical |
18 | ![]() | N, N, N’, N'-Tetrakis(4- methoxyphenyl)-9H- carbazole-3,6-diamine | 1630723-98-6 | OLED compound |
19 | ![]() | 9,9-(9H-fluorene-2,7-diyl) bis (N3, N3, N6, N6-tetrakis (4-methoxy phenyl) – 9H carbazole -3,6-diamine | NA | OLED compound |
20 | ![]() | 4,4-(9H-fluorene-2,7-diyl) bis (N, N-bis(4- methoxyphenyl) aniline | NA | OLED compound |
21 | ![]() | 4,4-(9-(4-(bis(4 –methoxyphenyl) amino) benzylidene) -9H-fluorene- 2,7-diyl) bis (N, N -bis (4- methoxyphenyl) aniline) | NA | OLED compound |
22 | ![]() | 1-(3-(aminomethyl)benzyl)-2-butyl-1H-imidazo[4,5- c]quinolin-4-amine | 1258457-58-7 | Vaccine Adjuvent |
23 | ![]() | a-Cyclopentylmandelic Acid | 427-49-6 | Intermediate for Glycopyronium bromide |
24 | ![]() | 1-Methyl-3-pyrrolidinol | 13220-33-2 | Intermediate for Glycopyronium bromide |
25 | ![]() | Isopropyl-β-D- thiogalactopyranoside (IPTG-Dioxane Free) | 367-93-1 | Reagent for Molecular biology and Fermentation |
26 | ![]() | L-Ribose | 24259-59-4 | SM for may novel anti viral drugs |
27 | ![]() | 7-Bromopyrrolo[2,1- f][1,2,4]triazin-4-amine (Remdesivir Intermediate) | 937046-98-5 | Intermediate for Remdesivir |
28 | ![]() | tert-butyl 3-((2-butyl-4- chloro-1H-imidazo[4,5- c]quinolin-1- yl)methyl)benzylcarbamate | 1258457-59-8 | Vaccine Adjuvant |
29 | ![]() | (R)-4-Propyldihydrofuran- 2(3H)-one | 63095-51-2 | Brivaracetam Intermediate |
30 | ![]() | 3-(4-Chlorophenyl)propan- 1-ol | 6282-88-8 | Capivasertib Intermediate |
31 | ![]() | (-)-Corey lactone diol | 32233-40-2 | KSM for Prostaglandin |
32 | ![]() | (-)-Corey Lactone Benzoate | 39746-00-4 | KSM for Prostaglandin |
33 | ![]() | Tbs-Coreylactone aldehyde | 64091-14-1 | KSM for Prostaglandin |
34 | ![]() | 1-(Cyanomethyl)imidazole | 98873-55-3 | KSM for Antifungal, Pesticides |
35 | ![]() | 2-(2'-hydroxyphenyl)thiophene | 106584-13-8 | Hetero cyclic Building Blocks |
36 | ![]() | (S)-Glycidyl 3- Nitrobenzenesulfonate | 115314-14-2 | Chiral Building Blocks |
![]() | 4-Hydroxyphentermine | 51706-55-9 | Derivatives for treatment of diabetes type II and related diseases , as well as respiratory diseases | |